BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA

Clinical trials for BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 3

New drug combo aims to shrink tumors for pancreatic cancer surgery

Disease control Not yet recruiting

This study is testing whether a new drug called IBI343, when given with standard chemotherapy before surgery, can help control borderline resectable pancreatic cancer. It aims to shrink tumors so they can be surgically removed, followed by more chemotherapy after surgery. The tri…

Matched conditions: BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA

Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control

Last updated Mar 16, 2026 15:24 UTC

BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA

Get alerted when new BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA trials appear

New drug combo aims to shrink tumors for pancreatic cancer surgery